EUVIMEDEUVIMED entdecken
Crossref

2'-Fucosyllactose restores the intestinal mucosal barrier in ulcerative colitis by inhibiting STAT3 palmitoylation and phosphorylation

Jinting Li, Yuping Wei, Chuan Liu, Xingzhou Guo, Zhengru Liu, Luyun Zhang, Shenglan Bao, Xiaohan Wu, Xiaoli Wang, Jixiang Zhang, Weiguo Dong

Clinical Nutrition · 2024-02 · 43 (2) · 380-394

DOI: 10.1016/j.clnu.2023.12.011 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Nutrition, 2024-02. Verfasst von Jinting Li und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Renmin Hospital of Wuhan University, Wuhan, Hubei Province, China; Key Laboratory of Hubei Province for Digestive Sys…. Hauptthemen laut MEDLINE: Colitis, Ulcerative, Colitis, Trisaccharides. Die Arbeit wurde bisher 37-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND & AIMS: 2'-Fucosyllactose (2'-FL), the primary constituent of human milk oligosaccharides, has been identified as a potential regulator of inflammation in inflammatory bowel disease. Despite this recognition, the specific mechanisms through which 2'-FL alleviates ulcerative colitis (UC) remain ambiguous. This study seeks to investigate the potential anti-inflammatory properties of 2'-FL concerning intestinal inflammation and uncover the associated mechanisms. METHODS: C57BL/6J mice were orally administered a daily dose of 500 mg/kg 2'-FL for 11 consecutive days, followed by the induction of colitis using 3 % (wt/vol) dextran sulfate sodium (DSS) for the final 6 days. Subsequently, a comprehensive range of techniques, including an Acyl-biotin exchange assay, fluorescein-isothiocyanate-labeled dextran assay, histopathology, ELISA, quantitative real-time PCR, Western blot, immunofluorescence staining, immunohistochemistry staining, Alcian blue-periodic acid schiff staining, TdT-mediated dUTP nick end labeling, transmission electron microscopy, iTRAQ quantitative proteomics, bioinformatics analysis, and the generation of signal transducer and activator of transcription 3 (STAT3) knockout mice, were employed to explore the relevant molecular mechanisms. RESULTS: Administration of 2'-FL significantly ameliorated DSS-induced colitis in mice and enhanced the integrity of the intestinal mucosal barrier. 2'-FL downregulated the phosphorylation of STAT3 and inhibited STAT3-related signaling pathways in colon tissues, which, in turn, reduced inflammatory responses. Interestingly, knockdown of STAT3 attenuated the protective effects of 2'-FL, highlighting that 2'-FL-mediated inflammatory attenuation is dependent on STAT3 expression. Additionally, 2'-FL could influence STAT3 activation by modulating the palmitoylation and depalmitoylation of STAT3. CONCLUSIONS: 2'-FL promotes the recovery of the intestinal mucosal barrier and suppresses inflammation in ulcerative colitis by inhibiting the palmitoylation and phosphorylation of STAT3.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colitis, UlcerativeColitisTrisaccharidesHumansAnimalsMiceColonSTAT3 Transcription FactorPhosphorylationLipoylationMice, Inbred C57BLInflammationDextran SulfateDisease Models, Animal

Stichwörter der Autor:innen

2'-fucosyllactoseHuman milk oligosaccharidesInflammationSTAT3Ulcerative colitis

Substanzen

2'-fucosyllactoseSTAT3 Transcription FactorDextran SulfateSTAT3 protein, humanTrisaccharides

Autor:innen und Institutionen

  • Department of Gastroenterology, Renmin Hospital of Wuhan University, Wuhan, Hubei Province, China; Key Laboratory of Hubei Province for Digestive System Disease, Wuhan, Hubei Province, China; Central Laboratory, Renmin…
  • Key Laboratory of Hubei Province for Digestive System Disease, Wuhan, Hubei Province, China; Department of Gastroenterology, The First Affiliated Hospital of Kunming Medical University, Kunming, China.
  • Key Laboratory of Hubei Province for Digestive System Disease, Wuhan, Hubei Province, China; Department of Gastroenterology, Shengjing Hospital of China Medical University, Shenyang, China.
  • Department of Plastic Surgery, Renmin Hospital of Wuhan University, Wuhan, Hubei Province, China.
  • Department of Gastroenterology, Renmin Hospital of Wuhan University, Wuhan, Hubei Province, China. Electronic address: zhangjixiang@whu.edu.cn.
  • Department of Gastroenterology, Renmin Hospital of Wuhan University, Wuhan, Hubei Province, China. Electronic address: dongweiguo@whu.edu.cn.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Li, J., Wei, Y., Liu, C., Guo, X., Liu, Z., Zhang, L., Bao, S., Wu, X., Wang, X., Zhang, J., & Dong, W. (2024). 2'-Fucosyllactose restores the intestinal mucosal barrier in ulcerative colitis by inhibiting STAT3 palmitoylation and phosphorylation. Clinical Nutrition, 43(2), 380-394. https://doi.org/10.1016/j.clnu.2023.12.011

Vancouver

Li J, Wei Y, Liu C, Guo X, Liu Z, Zhang L, et al. 2'-Fucosyllactose restores the intestinal mucosal barrier in ulcerative colitis by inhibiting STAT3 palmitoylation and phosphorylation. Clinical Nutrition. 2024;43(2):380-394. doi:10.1016/j.clnu.2023.12.011

BibTeX
@article{Li2024,
  author = {Li, Jinting and Wei, Yuping and Liu, Chuan and Guo, Xingzhou and Liu, Zhengru and Zhang, Luyun and Bao, Shenglan and Wu, Xiaohan and Wang, Xiaoli and Zhang, Jixiang and Dong, Weiguo},
  title = {2'-Fucosyllactose restores the intestinal mucosal barrier in ulcerative colitis by inhibiting STAT3 palmitoylation and phosphorylation},
  journal = {Clinical Nutrition},
  year = {2024},
  volume = {43},
  number = {2},
  pages = {380--394},
  doi = {10.1016/j.clnu.2023.12.011}
}
Kostenlos starten →